Veracyte Inc

Healthcare · Diagnostics & Research

44.70$ -6.3% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,486 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCYT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	70	101	93	88	84	79	71	65	119	121	124	252	260	275	267	257	454	457	1,025	1,027	1,186	1,188	1,174	1,144	1,126	1,156	1,157	1,161	1,125	1,115	1,200	1,234	1,275	1,300	1,315	1,344	1,368	1,406	1,436	1,486
Current Assets	43	74	66	63	58	54	47	42	95	97	91	220	228	188	181	173	370	376	362	371	229	243	238	235	239	249	252	259	271	286	290	321	357	372	383	415	449	488	522	575
Cash	32	59	52	46	41	34	27	24	78	78	68	193	196	159	153	147	345	349	324	328	164	173	164	153	170	154	178	191	202	216	209	236	274	239	186	219	316	363	263	300
Cash & Short-Term Investments	32	59	52	46	41	34	27	24	78	78	68	193	196	159	153	147	345	349	324	328	164	177	164	164	170	179	178	191	202	216	209	236	274	289	287	321	366	413	439	485
Receivables	6.3	8.8	9.1	11	12	13	13	13	12	13	17	20	24	19	19	15	18	18	28	32	40	41	42	40	40	44	45	42	39	40	47	50	49	47	54	51	48	45	50	54
Inventory	3.4	3.5	3.4	3.3	3.8	5.3	4.6	3.0	3.5	3.4	3.8	5.1	6.6	6.8	6.1	7.0	4.5	4.7	6.3	6.7	9.8	11	12	15	14	14	13	12	16	16	18	19	20	22	24	25	20	21	21	23
Property, Plant & Equipment	10	11	11	10	10	9.7	9.2	9.0	8.9	8.9	8.1	8.2	8.5	8.9	8.8	8.6	8.9	9.0	11	26	31	31	32	32	31	31	–	31	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	1.1	2.7	2.7	2.7	2.7	2.7	475	472	714	708	704	690	677	696	700	699	693	703	754	752	762	746	754	773	767	767	767	767
Intangible Assets	14	14	14	14	13	13	13	13	12	12	12	11	11	65	64	62	61	60	159	156	210	203	196	184	177	175	170	165	124	89	116	113	109	102	99	96	92	89	86	83
Total Liabilities	40	41	39	41	41	41	41	40	40	41	40	28	29	36	37	31	31	36	51	56	79	91	88	80	78	81	76	78	71	71	81	102	99	124	120	123	110	96	92	98
Current Liabilities	10	12	9.4	11	11	12	12	10	10	13	14	15	17	17	19	13	14	17	33	36	50	64	63	59	58	63	56	58	57	61	58	72	70	79	75	76	72	60	56	63
Short-Term Debt	–	26	25	25	25	25	25	25	–	1.4	1.5	1.4	1.4	1.4	1.5	1.5	1.5	1.6	2.9	2.9	3.5	4.8	4.9	5.1	5.1	4.1	4.1	5.0	5.0	5.1	6.0	7.2	7.3	7.5	7.4	6.4	4.3	4.1	4.3	5.8
Accounts Payable	3.1	2.4	2.6	2.3	3.2	3.9	3.4	2.0	1.2	2.5	4.1	4.1	5.6	2.3	7.7	2.2	1.9	3.1	7.1	8.5	11	12	11	10	11	12	16	13	13	13	12	12	9.7	8.6	16	11	5.5	4.6	6.9	8.0
Long-Term Debt	25	26	25	25	25	25	25	25	25	24	13	0.6	0.6	0.7	0.7	0.8	0.8	0.8	0.9	0.9	1.1	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	30	60	53	48	43	37	30	26	79	80	84	224	231	239	230	226	423	421	974	971	1,107	1,097	1,085	1,064	1,048	1,075	1,081	1,083	1,054	1,044	1,119	1,133	1,176	1,176	1,195	1,221	1,258	1,310	1,344	1,388
Retained Earnings	-176	-180	-188	-196	-203	-211	-220	-227	-231	-234	-236	-238	-239	-247	-258	-269	-274	-282	-323	-333	-347	-357	-372	-381	-390	-394	-402	-410	-440	-468	-470	-464	-449	-444	-437	-438	-419	-378	-349	-323
Shares Outstanding	28	32	34	34	34	34	34	34	39	41	41	46	49	49	50	50	55	58	63	67	70	71	71	71	72	72	72	72	73	73	75	77	78	80	80	80	80	81	81	82

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings